Tag: screening

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

Nipocalimab – the first and only neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and...

DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with...

Châtillon, France, June 2, 2026

DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons âgés...

Châtillon, France, le 02 juin (22 :30 CEST) 2026

Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics

NULISA™ DBS Extraction Kit recovers proteins from dried blood spot and dried plasma spot microsamples collected on leading third-party remote sampling devices

Musician supported by learning disability charity Hft to showcase his band’s musical journey at Sheffield DocFest

Matthew Watson lead singer of the 'most punk rock band in Britain' Ultimate Thunder, and his bandmates are the focus of a new documentary...

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

AQUIPTA® (atogepant) is now approved in the European Union for the acute treatment of migraine in adults, with or without aura, and for the...

Best Early Stage Presale Opportunity: Pepe Dollar Shines Against PEPETO in Q3 2026

Pepe Dollar ($PEPD) gains momentum as a best crypto presale while PEPETO nears fundraising completion during expanding Q3 2026 altcoin activity

Pepe Dollar ($PEPD) gains momentum as a best crypto presale while PEPETO nears fundraising completion during expanding Q3 2026 altcoin activity

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

- Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial

BronzeLens 2025 Hosts Nightly Features, Powerhouse Panels, and Signature Events

Among the participants are DeVale Ellis, Dakore Akande, Leon, Dr. Fahamu Pecou, Sean Freeman, Courtney Glaude, Alison Duke, and Ebony BlandingWednesday, August 20 to...

HeartSciences Announces Conference Participation and Investor Webinar

Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85

Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85

“Reparations: The Colonial Debt” to Premiere in Bamako on 16 August 2025

Pan-African People's Studios announces broadcast on ORTM and Africable following the screening BAMAKO, Mali, Aug. 14, 2025 /PRNewswire/ -- Pan-African People's Studios today announced the premiere...

ScanTech AI Announces Development of Next-Generation Enhancements for the SENTINEL® CT System

Atlanta, GA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI), a next-generation provider of AI-powered CT screening systems for aviation, customs, and critical infrastructure, is thrilled to announce the development of its upcoming AI-powered software, a groundbreaking upgrade exclusively for the SENTINEL CT Computed Tomography.

Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1Pivotal Phase 3 CYPRESS study enrollment on track to complete by late...

FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

— Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung Damage — — BRINSUPRI 10...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsScreening

Director/PDMR Shareholding

Aptean Appoints Yama Habibzai as Chief Marketing Officer

Taboola Announces Inclusion in Russell 3000® and 2000® Index